Overview

Low net, relative value Equity Long/Short strategy investing primarily in corporates predominantly listed in Greater China

Generalist approach with core focus on Financials, Healthcare, Consumer and TMT (technology, media, and telecom) sectors

Seeks to generate attractive risk-adjusted returns with low correlation and beta to both equity and credit markets

Portfolio construction is based primarily on fundamental bottom-up research combined with top-down macro analysis

The fund is actively managed without a reference to a benchmark.

The base currency of the Fund is USD.

Benefits

Alpha-focused, tightly managed beta, strategy targeting opportunities with market agnostic return drivers– with flexibility for factor/market-directional risk.

Similar to traditional equity long/short strategies in the US and Europe, but customized for uniqueness of Chinese market.

The fund is managed in accordance with UCITS rules & guidelines and provides investors enhanced reporting transparency and liquidity.

Risks

Counterparty Risk, a significant use of over-the-counter instruments exposes the Fund to potential significant counterparty default risk. The fund may use derivatives, which can reduce or increase investment risk (including the risk of loss due to the bankruptcy of the counterparty). This fund pursues a very active management style. Its performance may therefore deviate considerably from that of a comparable market return. Investments via Shanghai or Shenzhen Stock Connect are subject to additional risks, in particular quota limitations, custody risk, clearing/settlement risk and counterparty risk. Pronounced fluctuations in price are characteristic of emerging economies. Other characteristics include specific risks such as lower market transparency, regulatory hurdles, illiquidity of markets as well as political and social challenges.

Features

Product category
Alternative
O'Connor China Long/Short Alpha Strategies UCITS
Product domicile
Ireland
Portfolio management
UBS SA国际传谋 (Americas) LLC, New York
Fund management
UBS SA国际传谋 (Europe) S.A., Luxembourg
Custodian bank
J.P. Morgan Bank (Ireland) Plc
Representative for products established under foreign law
UBS Fund Management (Switzerland) AG
Day of inception
August 17, 2022
Currency of account
USD
Close of financial year
September 30
SFDR Classification
Art.6
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Ongoing costs p.a.
0.23% p.a.
Flat fee
0.23% p.a.
Performance fee
20.00%
Management fee
0.00% p.a.
Total expense ratio (TER)
0.13% p.a.
Minimum investment
n.a.
Securities no.
118580933
ISIN
IE000Y0ZSFU5
Bloomberg Ticker
USBNGHG ID

Performance and Prices

Percentage growth

as of February 10, 2026
Cumulative
USD(%) CHF(%) EUR(%)
YTD 2.11 -1.39 0.65
1M
3M
6M
1Y
2Y 9.61 -4.18 -3.35
3Y 33.12 10.23 19.29
5Y
ø p.a.5Y 10.00 3.30 6.05

Current data
Net asset value 10.02.2026 USD 133.77
High - last 12 months 28.01.2026 USD 135.54
Low - last 12 months 13.05.2025 USD 115.30
Assets of the unit class in mn 10.02.2026 USD 0.24
Total product assets in mn 10.02.2026 USD 218.99

Structures

Fees

Ongoing costs p.a.
0.2300%
Flat fee
0.2300%
Management fee p.a.
0.0000%
Performance Fee
20.0000%

Distributions

No distributions. Continuous reinvestment of income.

Sales Authorisations

Market
Sales authorisations status
Australia
Institutional Only*
Ireland
Registered
Switzerland
Registered

Literature

en
de
fr
it
es
Brochures
Document type
Document Language
Fact Sheet
fr fr
it it
es es
en en
de de
Fact Sheet - Alternative
de de
es es
fr fr
en en
it it
Fact Sheet - O'Connor China Long/Short Alpha Strategies UCITS
fr fr
it it
es es
en en
de de
Agreement / Prospectus
Document type
Document Language
Prospectus
Supplement
Key Information Document
Past performance
Previous performance scenario
Annual and semi-annual report (accounting on September 30)
Document type
Document Language
Annual report
Semi-annual report
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.